| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| P794694 | MACKLIN | 溴化双哌雄双酯 溴化物 | 10mM in DMSO | 880元/1ml; | 展开 |
|
| P832871 | MACKLIN | 溴化双哌雄双酯 溴化物 | ≥99% | 179元/25mg; 299元/100mg; 499元/250mg; 1399元/1g; 4611元/5g; | 展开 |
|
| P0250000 | | Pancuronium bromide | European Pharmacopoeia (EP) Reference Standard | 1559.78元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 20 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C35H60Br2N2O4 | | 分子量 | 732.67 | | Beilstein | 4226892 | | MDL编号 | MFCD00079223 | | PubChem化学物质编号 | 329820026 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | [Br-].[Br-].[H][C@@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@@H](OC(C)=O)[C@H](C[C@@]34[H])[N+]5(C)CCCCC5)[C@@]1(C)C[C@@H]([C@H](C2)OC(C)=O)[N+]6(C)CCCCC6 | | InChI | 1S/C35H60N2O4.2BrH/c1-24(38)40-32-21-26-13-14-27-28(35(26,4)23-31(32)37(6)19-11-8-12-20-37)15-16-34(3)29(27)22-30(33(34)41-25(2)39)36(5)17-9-7-10-18-36;;/h26-33H,7-23H2,1-6H3;2*1H/q+2;;/p-2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-;;/m0../s1 | | InChI key | NPIJXCQZLFKBMV-YTGGZNJNSA-L | | Gene Information | human ... CHRNA1(1134), CHRNB1(1140), CHRND(1144), CHRNE(1145), CHRNG(1146) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P330 + P331 + P310 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0000577 | | Pancuronium bromide for system suitability | European Pharmacopoeia (EP) Reference Standard | 1559.78元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C35H60Br2N2O4 | | 分子量 | 732.67 | | Beilstein | 4226892 | | MDL编号 | MFCD00079223 | | PubChem化学物质编号 | 329831030 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | [Br-].[Br-].[H][C@@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@@H](OC(C)=O)[C@H](C[C@@]34[H])[N+]5(C)CCCCC5)[C@@]1(C)C[C@@H]([C@H](C2)OC(C)=O)[N+]6(C)CCCCC6 | | InChI | 1S/C35H60N2O4.2BrH/c1-24(38)40-32-21-26-13-14-27-28(35(26,4)23-31(32)37(6)19-11-8-12-20-37)15-16-34(3)29(27)22-30(33(34)41-25(2)39)36(5)17-9-7-10-18-36;;/h26-33H,7-23H2,1-6H3;2*1H/q+2;;/p-2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-;;/m0../s1 | | InChI key | NPIJXCQZLFKBMV-YTGGZNJNSA-L | | Gene Information | human ... CHRNA1(1134), CHRNB1(1140), CHRND(1144), CHRNE(1145), CHRNG(1146) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P330 + P331 + P310 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| P1918 | Sigma-Aldrich | Pancuronium bromide | | 921.1元/10 MG; 3234.51元/50 MG; 4568.36元/100 MG; 9148.3元/250 MG; | 展开 |
产品说明 一般描述 泮库溴铵是一种双季氨基类固醇。它可以阻断心脏中的毒蕈碱型乙酰胆碱受体(M2)。 泮库溴铵具有溶血和拟交感神经特性。它与心动过速和高血压有关。 应用 泮库溴铵已被用作多种实验中的镇痛药。 生化/生理作用 氨基甾体神经肌肉阻滞剂;骨骼肌松弛剂 特点和优势 该化合物由Organon开发。要浏览其他药物开发化合物和批准的药物/候选药物列表,单击此处。 这种化合物是神经科学研究的特色产品。点击此处发现更多特色神经科学产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。 包装 无底玻璃瓶。内含物在插入的融合锥体内。 基本信息 | 经验(实验)分子式 | C35H60Br2N2O4 | | 分子量 | 732.67 | | Beilstein | 4226892 | | EC 号 | 239-532-5 | | MDL编号 | MFCD00079223 | | PubChem化学物质编号 | 24278623 | | NACRES | NA.77 |
产品性质 | 质量水平 | 100 | | 创始人 | Organon | | SMILES string | [Br-].[Br-].[H][C@@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@@H](OC(C)=O)[C@H](C[C@@]34[H])[N+]5(C)CCCCC5)[C@@]1(C)C[C@@H]([C@H](C2)OC(C)=O)[N+]6(C)CCCCC6 | | InChI | 1S/C35H60N2O4.2BrH/c1-24(38)40-32-21-26-13-14-27-28(35(26,4)23-31(32)37(6)19-11-8-12-20-37)15-16-34(3)29(27)22-30(33(34)41-25(2)39)36(5)17-9-7-10-18-36;;/h26-33H,7-23H2,1-6H3;2*1H/q+2;;/p-2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-;;/m0../s1 | | InChI key | NPIJXCQZLFKBMV-YTGGZNJNSA-L | | Gene Information | human ... CHRNA1(1134), CHRNB1(1140), CHRND(1144), CHRNE(1145), CHRNG(1146) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P310 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Faceshields, Gloves |
|
| 1494217 | USP | Pancuronium bromide | United States Pharmacopeia (USP) Reference Standard | 5804.47元/500 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C35H60Br2N2O4 | | 分子量 | 732.67 | | Beilstein | 4226892 | | MDL编号 | MFCD00079223 | | PubChem化学物质编号 | 329750661 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | [Br-].[Br-].[H][C@@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@@H](OC(C)=O)[C@H](C[C@@]34[H])[N+]5(C)CCCCC5)[C@@]1(C)C[C@@H]([C@H](C2)OC(C)=O)[N+]6(C)CCCCC6 | | InChI | 1S/C35H60N2O4.2BrH/c1-24(38)40-32-21-26-13-14-27-28(35(26,4)23-31(32)37(6)19-11-8-12-20-37)15-16-34(3)29(27)22-30(33(34)41-25(2)39)36(5)17-9-7-10-18-36;;/h26-33H,7-23H2,1-6H3;2*1H/q+2;;/p-2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-;;/m0../s1 | | InChI key | NPIJXCQZLFKBMV-YTGGZNJNSA-L | | Gene Information | human ... CHRNA1(1134), CHRNB1(1140), CHRND(1144), CHRNE(1145), CHRNG(1146) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P330 + P331 + P310 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP276 | | Pancuronium bromide | British Pharmacopoeia (BP) Reference Standard | 2390.55元/25 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C35H60Br2N2O4 | | 分子量 | 732.67 | | Beilstein | 4226892 | | MDL编号 | MFCD00079223 |
产品性质 | 等级 | pharmaceutical primary standard | | 质量 | British Pharmacopoeia (BP) Reference Standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | [Br-].[Br-].[H][C@@]12CC[C@]3([H])[C@]([H])(CC[C@]4(C)[C@@H](OC(C)=O)[C@H](C[C@@]34[H])[N+]5(C)CCCCC5)[C@@]1(C)C[C@@H]([C@H](C2)OC(C)=O)[N+]6(C)CCCCC6 | | InChI | 1S/C35H60N2O4.2BrH/c1-24(38)40-32-21-26-13-14-27-28(35(26,4)23-31(32)37(6)19-11-8-12-20-37)15-16-34(3)29(27)22-30(33(34)41-25(2)39)36(5)17-9-7-10-18-36;;/h26-33H,7-23H2,1-6H3;2*1H/q+2;;/p-2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-;;/m0../s1 | | InChI key | NPIJXCQZLFKBMV-YTGGZNJNSA-L | | Gene Information | human ... CHRNA1(1134), CHRNB1(1140), CHRND(1144), CHRNE(1145), CHRNG(1146) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 + P330 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|